FLT3 and acute myeloid leukemia: Here, we report on two cases of FLT3-ITD positive AML in patients unfit for intensive chemotherapy being treated with sequential therapy consisting of LDAC followed by oral administration of sorafenib resulting in rapid induction of complete molecular remission with no significant toxicity arising.